These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Epidemiology and Molecular Basis of Resistance to Fluconazole Among Clinical Candida parapsilosis Isolates in Kuwait. Asadzadeh M, Ahmad S, Al-Sweih N, Khan Z. Microb Drug Resist; 2017 Dec; 23(8):966-972. PubMed ID: 28353392 [Abstract] [Full Text] [Related]
4. Candida and candidaemia. Susceptibility and epidemiology. Arendrup MC. Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246 [Abstract] [Full Text] [Related]
6. Development of fluconazole resistance in a series of Candida parapsilosis isolates from a persistent candidemia patient with prolonged antifungal therapy. Zhang L, Xiao M, Watts MR, Wang H, Fan X, Kong F, Xu YC. BMC Infect Dis; 2015 Aug 18; 15():340. PubMed ID: 26282840 [Abstract] [Full Text] [Related]
8. Clinical azole cross-resistance in Candida parapsilosis is related to a novel MRR1 gain-of-function mutation. Branco J, Ryan AP, Pinto E Silva A, Butler G, Miranda IM, Rodrigues AG. Clin Microbiol Infect; 2022 Dec 18; 28(12):1655.e5-1655.e8. PubMed ID: 36028086 [Abstract] [Full Text] [Related]
9. Multidrug Transporters and Alterations in Sterol Biosynthesis Contribute to Azole Antifungal Resistance in Candida parapsilosis. Berkow EL, Manigaba K, Parker JE, Barker KS, Kelly SL, Rogers PD. Antimicrob Agents Chemother; 2015 Oct 18; 59(10):5942-50. PubMed ID: 26169412 [Abstract] [Full Text] [Related]
15. Drug resistance genes and trailing growth in Candida albicans isolates. Lee MK, Williams LE, Warnock DW, Arthington-Skaggs BA. J Antimicrob Chemother; 2004 Feb 18; 53(2):217-24. PubMed ID: 14688046 [Abstract] [Full Text] [Related]
16. Induction of Candida albicans drug resistance genes by hybrid zinc cluster transcription factors. Schneider S, Morschhäuser J. Antimicrob Agents Chemother; 2015 Jan 18; 59(1):558-69. PubMed ID: 25385116 [Abstract] [Full Text] [Related]